SNDX-5613
|
|
SNDX-5613 Eigenschaften
- Siedepunkt:
- 739.1±70.0 °C(Predicted)
- Dichte
- 1.28±0.1 g/cm3(Predicted)
- L?slichkeit
- DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM)
- pka
- 11.10±0.40(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to off-white
Sicherheit
SNDX-5613 Chemische Eigenschaften,Einsatz,Produktion Methoden
SNDX-5613 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
SNDX-5613 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 60)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32965 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
Wuhan Nutra Biotechnology Co.,Ltd | +8617786394783 |
nutrabiotech@outlook.com | China | 300 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 |
sales@sarms4muscle.com | China | 10473 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 |
sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8467 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57505 | 58 |
Suzhou ARTK Medchem Co., Ltd. | +86-512-68323658 +86-18168183658 |
sales1@artkmedchem.com | China | 39004 | 58 |
Shanghai SuperLan Chemcial Technique Centre | 021-2022843681 15618226720 |
lucy@atkchemical.com | China | 9987 | 58 |
- SNDX-5613
- acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid
- Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
- SNDX-5613 SNDX5613
- Revumenib
- N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide
- SNDX-5613, 10 mM in DMSO
- 2169919-21-3